Page last updated: 2024-08-17

desoxycorticosterone and Cirrhosis

desoxycorticosterone has been researched along with Cirrhosis in 56 studies

Research

Studies (56)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (5.36)18.2507
2000's30 (53.57)29.6817
2010's20 (35.71)24.3611
2020's3 (5.36)2.80

Authors

AuthorsStudies
Gao, Y; Guo, X; Liang, H; Liu, B; Nie, J; Wen, S; Yu, W; Zou, H1
Cui, Z; Gao, Y; Liang, H; Liu, B; Nie, J; Song, J; Wen, S; Yu, W1
Bienvenu, LA; Clyne, CD; Delbridge, LMD; Fletcher, EK; Fuller, PJ; Kennaway, DR; Morgan, J; Rickard, AJ; Young, MJ1
Cai, L; Chen, C; Li, H; Lu, C; Qian, Y; Tan, Y; Weng, H1
Fan, B; Li, Q; Ma, L; Wang, L; Wu, J; Zhou, J2
Fuller, PJ; Morgan, J; Shen, JZ; Tesch, GH; Young, MJ1
Chrissobolis, S; Miller, AA; Morgan, J; Rickard, AJ; Sobey, CG; Young, MJ1
Chrissobolis, S; Drummond, GR; Fuller, PJ; Morgan, J; Rickard, AJ; Shen, JZ; Tesch, GH; Young, MJ1
He, L; Hu, Z; Liang, H; Ma, Z; Peng, H; Wang, Y1
Hisamichi, M; Hoshino, S; Ichikawa, D; Kamijo-Ikemori, A; Kimura, K; Natsuki, T; Shibagaki, Y; Sugaya, T1
Aicher, WK; Alexander, D; Artunc, F; Friedrich, B; Janessa, A; Lang, F; Müller, GA; Risler, T1
Dorrance, AM1
Fuller, PJ; Funder, JW; Morgan, J; Rickard, AJ; Tesch, G; Young, MJ1
Jadhav, A; Ndisang, JF1
Brown, L; Fairlie, DP; Fenning, A; Halili, MA; Iyer, A; Le, GT; Lim, J; Reid, RC1
Chen, R; Eisner, C; Hu, X; Huang, Y; Kopp, JB; Leelahavanichkul, A; Mizel, D; Schnermann, J; Star, RA; Wright, EC; Yan, Q; Yuen, PS; Zhou, H1
Brown, L; Chan, V; Fenning, A; Hoey, A; Iyer, A1
Furuichi, K; Kaneko, S; Kitagawa, K; Matsushima, K; Mukaida, N; Sakai, N; Shimizu, K; Wada, T1
Chin-Dusting, J; Chu, PY; Du, XJ; Kaye, DM; Kiriazis, H; Marshall, T; Zatta, A1
Wang, DH; Wang, Y1
Fujisawa, G; Hirahara, I; Iwazu, Y; Kusano, E; Muto, S; Takeda, S1
He, L; Hua, J; Li, Q; Ma, L; Yu, J; Zhou, J1
Bienvenu, LA; Cranston, GA; Delbridge, LM; Fletcher, EK; Morgan, J; Reichelt, ME; Rickard, AJ; Shen, JZ; Young, MJ1
Chen, HW; Feng, KF; He, LF; Hu, H; Hua, JS; Li, Q; Ma, LK; Wang, L; Yu, H; Zhou, JL1
Dieterich, M; Gögebakan, O; Kossmehl, P; Kreutz, R; Rothermund, L; Vetter, R; Yagil, C; Yagil, Y1
Funder, JW1
Dilley, R; Funder, JW; Moussa, L; Young, MJ1
Fujisawa, G; Fujita, N; Ishibashi, S; Itabashi, N; Kusano, E; Muto, S; Okada, K1
Amiri, F; Diep, QN; Iglarz, M; Paradis, P; Schiffrin, EL; Touyz, RM; Viel, EC1
Funder, J; Young, M1
Funder, JW; Young, M1
Irukayama-Tomobe, Y; Miyauchi, T; Ogata, T; Sakai, S; Takanashi, M; Yamaguchi, I1
Hirade, S; Inoue, H; Kagitani, S; Takahashi, T; Takata, M; Ueno, H1
Perlini, S1
Amiri, F; Gannon, P; Pu, Q; Schiffrin, EL1
Bledsoe, G; Chao, J; Chao, L; Xia, CF1
Grobe, JL; Katovich, MJ; Mao, H; Mecca, AP1
Belaiba, RS; Berchtold, S; Dalton, ND; Daut, J; Flögel, U; Friedrich, B; Görlach, A; Grahammer, F; Huang, DY; Hussain, A; Kandolf, R; Klingel, K; Kuhl, D; Lang, F; Osswald, H; Ross, J; Schrader, J; Vallon, V; Wulff, P; Wyatt, AW1
Fuller, PJ; Funder, JW; Lam, EY; Nikolic-Paterson, DJ; Young, MJ1
Brown, L; Hoey, A; Levick, S; Loch, D1
Brown, L; Hoey, A; Loch, D1
Fuller, PJ; Funder, JW; Rickard, AJ; Young, MJ1
Fuller, PJ; Funder, JW; Morgan, J; Rickard, AJ; Young, MJ1
Fujisawa, G; Ishibashi, S; Iwazu, Y; Kusano, E; Muto, S; Nakazawa, E; Okada, K1
Bernhardt, R; Carapito, C; Hwang, KH; Leize-Wagner, E; Van Dorsselaer, A; Wilzewski, B; Zöllner, S1
Funder, J; Head, G; Young, M1
Clozel, JP; Clozel, M; Gonzales, MF; Hess, P; Heudes, D; Karam, H; Löffler, BM1
Border, WA; Noble, NA1
Chao, J; Chao, L; Dobrzynski, E; Wang, C1
Ammarguellat, F; Larouche, I; Schiffrin, EL1
Dilley, R; Fujisawa, G; Fullerton, MJ; Funder, JW1
Brown, L; Fenning, A; Margolin, SB; Mirkovic, S; Seymour, AM; Strachan, A; Taylor, SM1
Amiri, F; Ammarguellat, FZ; Gannon, PO; Schiffrin, EL1
Cordasic, N; Hartner, A; Hilgers, KF; Klanke, B; Müller, U; Sterzel, RB1

Reviews

2 review(s) available for desoxycorticosterone and Cirrhosis

ArticleYear
New biology of aldosterone, and experimental studies on the selective aldosterone blocker eplerenone.
    American heart journal, 2002, Volume: 144, Issue:5 Suppl

    Topics: Aldosterone; Animals; Cardiomegaly; Clinical Trials as Topic; Desoxycorticosterone; Eplerenone; Fibrosis; Heart; Heart Failure; Humans; Hypertension; Mineralocorticoid Receptor Antagonists; Myocardium; Rats; Rats, Inbred SHR; Receptors, Mineralocorticoid; Spironolactone

2002
TGF-beta in kidney fibrosis: a target for gene therapy.
    Kidney international, 1997, Volume: 51, Issue:5

    Topics: Animals; Desoxycorticosterone; Diabetic Nephropathies; Fibrosis; Genetic Therapy; Glomerulonephritis; Graft Rejection; Humans; Kidney; Kidney Transplantation; Transforming Growth Factor beta

1997

Other Studies

54 other study(ies) available for desoxycorticosterone and Cirrhosis

ArticleYear
Interferon regulatory factor 4 deletion protects against kidney inflammation and fibrosis in deoxycorticosterone acetate/salt hypertension.
    Journal of hypertension, 2023, 05-01, Volume: 41, Issue:5

    Topics: Acetates; Animals; Blood Pressure; Desoxycorticosterone; Desoxycorticosterone Acetate; Fibrosis; Hypertension; Hypertension, Renal; Inflammation; Interferon Regulatory Factors; Kidney; Mice; Mice, Knockout

2023
JMJD3 ablation in myeloid cells confers renoprotection in mice with DOCA/salt-induced hypertension.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2023, Volume: 46, Issue:8

    Topics: Animals; Blood Pressure; Desoxycorticosterone; Desoxycorticosterone Acetate; Fibrosis; Hypertension; Hypertension, Renal; Inflammation; Kidney; Macrophages; Mice; Mice, Inbred C57BL

2023
Interferon regulatory factor 4 deletion protects against kidney inflammation and fibrosis in deoxycorticosterone acetate/salt hypertension: Erratum.
    Journal of hypertension, 2023, 11-01, Volume: 41, Issue:11

    Topics: Acetates; Blood Pressure; Desoxycorticosterone; Desoxycorticosterone Acetate; Fibrosis; Humans; Hypertension; Inflammation; Interferon Regulatory Factors; Kidney; Nephritis

2023
Deoxycorticosterone/Salt-Mediated Cardiac Inflammation and Fibrosis Are Dependent on Functional CLOCK Signaling in Male Mice.
    Endocrinology, 2017, 09-01, Volume: 158, Issue:9

    Topics: Animals; Cells, Cultured; CLOCK Proteins; Desoxycorticosterone; Fibrosis; Heart; Male; Mice; Mice, Inbred CBA; Mice, Transgenic; Myocarditis; Myocardium; Rats; Receptors, Mineralocorticoid; Signal Transduction; Sodium Chloride

2017
Urinary miR-21 as a potential biomarker of hypertensive kidney injury and fibrosis.
    Scientific reports, 2017, 12-18, Volume: 7, Issue:1

    Topics: Acetylglucosaminidase; Acute Kidney Injury; Animals; Biomarkers; Creatinine; Desoxycorticosterone; Fibrosis; Hypertension; Hypertension, Renal; Kidney; Kidney Tubules; Male; Mice; Mice, Inbred C57BL; MicroRNAs; Urinary Tract

2017
Correlation between platelet-derived growth factor signaling pathway and inflammation in desoxycorticosterone-induced salt-sensitive hypertensive rats with myocardial fibrosis.
    International journal of clinical and experimental pathology, 2013, Volume: 6, Issue:11

    Topics: Animals; Blood Pressure; Desoxycorticosterone; Disease Models, Animal; Fibrosis; Hypertension; Male; Myocarditis; Myocardium; Platelet-Derived Growth Factor; Rats; Rats, Sprague-Dawley; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; RNA, Messenger; Signal Transduction; Sodium Chloride, Dietary

2013
Role of PDGFs/PDGFRs signaling pathway in myocardial fibrosis of DOCA/salt hypertensive rats.
    International journal of clinical and experimental pathology, 2014, Volume: 7, Issue:1

    Topics: Animals; Cardiomyopathies; Desoxycorticosterone; Disease Models, Animal; Fibroblasts; Fibrosis; Hypertension; Immunohistochemistry; Male; Mineralocorticoids; Myofibroblasts; Platelet-Derived Growth Factor; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Receptors, Platelet-Derived Growth Factor; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction

2014
CCL2-dependent macrophage recruitment is critical for mineralocorticoid receptor-mediated cardiac fibrosis, inflammation, and blood pressure responses in male mice.
    Endocrinology, 2014, Volume: 155, Issue:3

    Topics: Animals; Blood Pressure; Chemokine CCL2; Collagen; Cytokines; Desoxycorticosterone; Fibroblasts; Fibrosis; Immunohistochemistry; Inflammation; Macrophages; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocardium; Radioimmunoassay; Receptors, Mineralocorticoid; Time Factors

2014
Endothelial cell mineralocorticoid receptors regulate deoxycorticosterone/salt-mediated cardiac remodeling and vascular reactivity but not blood pressure.
    Hypertension (Dallas, Tex. : 1979), 2014, Volume: 63, Issue:5

    Topics: Aldosterone; Animals; Blood Pressure; Cardiovascular Physiological Phenomena; Cells, Cultured; Connective Tissue Growth Factor; Desoxycorticosterone; Disease Models, Animal; Endothelium, Vascular; Fibrosis; Humans; Hypertension; Intercellular Adhesion Molecule-1; Mice; Mice, Knockout; Myocarditis; Receptors, Mineralocorticoid; Sodium Chloride; Vascular Resistance; Ventricular Remodeling

2014
Cardiac Tissue Injury and Remodeling Is Dependent Upon MR Regulation of Activation Pathways in Cardiac Tissue Macrophages.
    Endocrinology, 2016, Volume: 157, Issue:8

    Topics: Animals; Cells, Cultured; Desoxycorticosterone; Fibrosis; Heart; Inflammation; Macrophages; Male; Mice; Mice, Transgenic; Myocardium; Receptors, Mineralocorticoid; Signal Transduction; Sodium Chloride, Dietary; T-Lymphocytes; Ventricular Remodeling

2016
CXCL16 Deficiency Attenuates Renal Injury and Fibrosis in Salt-Sensitive Hypertension.
    Scientific reports, 2016, 06-29, Volume: 6

    Topics: Acute Kidney Injury; Animals; Blood Pressure; Chemokine CXCL16; Desoxycorticosterone; Fibrosis; Hypertension, Renal; Mice; Mice, Knockout; Sodium Chloride, Dietary

2016
Role of angiotensin II type 1a receptor in renal injury induced by deoxycorticosterone acetate-salt hypertension.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2017, Volume: 31, Issue:1

    Topics: Animals; Desoxycorticosterone; Fatty Acid-Binding Proteins; Female; Fibrosis; Gene Expression Regulation; Humans; Hypertension; Kidney Diseases; Low Density Lipoprotein Receptor-Related Protein-2; Mice; Mice, Knockout; Mice, Transgenic; Receptor, Angiotensin, Type 1; Sodium Chloride

2017
DOCA and TGF-beta induce early growth response gene-1 (Egr-1) expression.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2008, Volume: 22, Issue:5-6

    Topics: Animals; Cell Line; Desoxycorticosterone; Disease Models, Animal; Early Growth Response Protein 1; Fibrosis; Gene Expression Regulation; Humans; Kidney Diseases; Mice; Sodium Chloride; Time Factors; Transfection; Transforming Growth Factor beta

2008
Are macrophages the foot soldiers in the war waged by aldosterone against the heart?
    Hypertension (Dallas, Tex. : 1979), 2009, Volume: 54, Issue:3

    Topics: Aldosterone; Animals; Blood Pressure; Desoxycorticosterone; Fibrosis; Macrophages; Mice; Mice, Knockout; Models, Biological; Monocytes; Myocardium; Receptors, Mineralocorticoid; Sodium Chloride, Dietary

2009
Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone/salt-induced cardiac fibrosis and increased blood pressure.
    Hypertension (Dallas, Tex. : 1979), 2009, Volume: 54, Issue:3

    Topics: Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Blood Pressure; Chemokine CCL2; Collagen; Desoxycorticosterone; Female; Fibrosis; Gene Expression; Immunohistochemistry; Macrophages; Male; Mice; Mice, Knockout; Monocytes; Myocardium; Nephrectomy; Plasminogen Activator Inhibitor 1; Random Allocation; Receptors, Mineralocorticoid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sodium Chloride, Dietary

2009
The heme oxygenase system attenuates pancreatic lesions and improves insulin sensitivity and glucose metabolism in deoxycorticosterone acetate hypertension.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2010, Volume: 298, Issue:1

    Topics: Adiponectin; Animals; Blood Pressure; Desoxycorticosterone; Disease Models, Animal; Fibrosis; Glucose; Heme Oxygenase (Decyclizing); Hemin; Hypertension; Insulin; Insulin Resistance; Male; Muscle, Skeletal; Necrosis; Oxidative Stress; Pancreas; Rats; Rats, Sprague-Dawley; Signal Transduction

2010
Antifibrotic activity of an inhibitor of histone deacetylases in DOCA-salt hypertensive rats.
    British journal of pharmacology, 2010, Volume: 159, Issue:7

    Topics: Animals; Desoxycorticosterone; Fibrosis; Heart; Histone Deacetylase Inhibitors; Hydroxamic Acids; Hypertension; Male; Rats; Rats, Wistar; Vorinostat

2010
Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model.
    Kidney international, 2010, Volume: 78, Issue:11

    Topics: Albuminuria; Anemia; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Chronic Disease; Desoxycorticosterone; Disease Models, Animal; Disease Progression; Fibrosis; Genetic Predisposition to Disease; Glomerulonephritis; Heart Diseases; Hydralazine; Hypertension; Imidazoles; Infusion Pumps, Implantable; Infusions, Subcutaneous; Kidney; Kidney Diseases; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Nephrectomy; Sodium Chloride, Dietary; Species Specificity; Telemetry; Tetrazoles; Time Factors; X-Ray Microtomography

2010
Resveratrol improves cardiovascular function in DOCA-salt hypertensive rats.
    Current pharmaceutical biotechnology, 2011, Mar-01, Volume: 12, Issue:3

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Desoxycorticosterone; Fibrosis; Heart; Heart Ventricles; Humans; Hypertension; Male; Mineralocorticoids; Rats; Rats, Wistar; Resveratrol; Sodium Chloride, Dietary; Stilbenes; Ventricular Remodeling

2011
Fractalkine and its receptor, CX3CR1, promote hypertensive interstitial fibrosis in the kidney.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2011, Volume: 34, Issue:6

    Topics: Animals; Antigens, Differentiation; Chemokine CX3CL1; CX3C Chemokine Receptor 1; Desoxycorticosterone; Fibrosis; Hypertension; Kidney; Macrophages; Male; Mice; Mice, Inbred C57BL; Receptors, Chemokine; Signal Transduction; Transforming Growth Factor beta1

2011
CXCR4 antagonism attenuates the cardiorenal consequences of mineralocorticoid excess.
    Circulation. Heart failure, 2011, Volume: 4, Issue:5

    Topics: Animals; Chemokine CXCL12; Desoxycorticosterone; Disease Models, Animal; Fibrosis; Heart; Hypertension; Hypertrophy, Left Ventricular; Kidney; Male; Mice; Mice, Inbred C57BL; Mineralocorticoids; Myocardium; Pyridines; Receptors, CXCR4; Signal Transduction; Up-Regulation

2011
Protective effect of TRPV1 against renal fibrosis via inhibition of TGF-β/Smad signaling in DOCA-salt hypertension.
    Molecular medicine (Cambridge, Mass.), 2011, Volume: 17, Issue:11-12

    Topics: Animals; Blood Pressure; Desoxycorticosterone; Fibronectins; Fibrosis; Heart Rate; Hypertension; Kidney; Kidney Cortex; Kidney Diseases; Kidney Glomerulus; Mice; Phosphorylation; Protective Agents; Signal Transduction; Smad Proteins; Smad2 Protein; Smad3 Protein; Time Factors; Transforming Growth Factor beta; TRPV Cation Channels

2011
Matrix metalloproteinase 2 induces epithelial-mesenchymal transition in proximal tubules from the luminal side and progresses fibrosis in mineralocorticoid/salt-induced hypertensive rats.
    Journal of hypertension, 2011, Volume: 29, Issue:12

    Topics: Animals; Collagen; Desoxycorticosterone; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Epithelial-Mesenchymal Transition; Fibrosis; Hypertension; Kidney; Kidney Tubules, Proximal; Male; Matrix Metalloproteinase 2; Nephrectomy; Nephritis, Interstitial; Rats; Rats, Sprague-Dawley; Sodium Chloride; Spironolactone

2011
Anti-fibrotic effect of Aliskiren in rats with deoxycorticosterone induced myocardial fibrosis and its potential mechanism.
    Bosnian journal of basic medical sciences, 2012, Volume: 12, Issue:2

    Topics: Amides; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Blotting, Western; Cardiomyopathies; Cardiotonic Agents; Collagen; Desoxycorticosterone; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Fumarates; Heart Ventricles; Indicators and Reagents; Male; Matrix Metalloproteinase 9; Myocardium; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Renin

2012
Cardiomyocyte mineralocorticoid receptors are essential for deoxycorticosterone/salt-mediated inflammation and cardiac fibrosis.
    Hypertension (Dallas, Tex. : 1979), 2012, Volume: 60, Issue:6

    Topics: Animals; Desoxycorticosterone; Fibrosis; Inflammation; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Knockout; Myocardium; Myocytes, Cardiac; Receptors, Mineralocorticoid; Sodium Chloride, Dietary; Ventricular Remodeling

2012
Imatinib attenuates myocardial fibrosis in association with inhibition of the PDGFRα activity.
    Arquivos brasileiros de cardiologia, 2012, Volume: 99, Issue:6

    Topics: Animals; Benzamides; Blood Pressure; Blotting, Western; Desoxycorticosterone; Disease Models, Animal; Endomyocardial Fibrosis; Fibronectins; Fibrosis; Hypertension; Imatinib Mesylate; Male; Nephrectomy; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; Tenascin; Treatment Outcome

2012
Endothelin-A receptor blockade prevents left ventricular hypertrophy and dysfunction in salt-sensitive experimental hypertension.
    Circulation, 2002, Oct-29, Volume: 106, Issue:18

    Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Calcium-Binding Proteins; Calcium-Transporting ATPases; Desoxycorticosterone; Disease Models, Animal; Endothelin Receptor Antagonists; Fibrosis; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Male; Organ Size; Phenylpropionates; Pyrimidines; Rats; Rats, Inbred Strains; Receptor, Endothelin A; RNA, Messenger; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Sodium Chloride; Ventricular Dysfunction, Left

2002
Early inflammatory responses in experimental cardiac hypertrophy and fibrosis: effects of 11 beta-hydroxysteroid dehydrogenase inactivation.
    Endocrinology, 2003, Volume: 144, Issue:3

    Topics: 11-beta-Hydroxysteroid Dehydrogenases; Animals; Blood Pressure; Carbenoxolone; Cardiomegaly; Coronary Disease; Desoxycorticosterone; Enzyme Inhibitors; Eplerenone; Fibrosis; Heart; Hydroxysteroid Dehydrogenases; Kidney; Male; Mineralocorticoid Receptor Antagonists; Muscle, Smooth, Vascular; Myocardium; Nephrectomy; Organ Size; Rats; Rats, Sprague-Dawley; Sodium Chloride; Solutions; Spironolactone; Vasculitis

2003
Na/H exchange isoform 1 is involved in mineralocorticoid/salt-induced cardiac injury.
    Hypertension (Dallas, Tex. : 1979), 2003, Volume: 41, Issue:3

    Topics: Animals; Blood Pressure; Cardiomegaly; Collagen; Desoxycorticosterone; Fibrosis; Guanidines; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Rats; Rats, Sprague-Dawley; Sodium Chloride; Sodium-Hydrogen Exchangers; Spironolactone; Sulfones

2003
Peroxisome proliferator-activated receptor-alpha and receptor-gamma activators prevent cardiac fibrosis in mineralocorticoid-dependent hypertension.
    Hypertension (Dallas, Tex. : 1979), 2003, Volume: 42, Issue:4

    Topics: Animals; Blood Pressure; Body Weight; Cardiomegaly; Collagen; Desoxycorticosterone; Endothelin-1; Endothelins; Fenofibrate; Fibrosis; Heart; Heart Ventricles; Hypertension; Myocardium; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Ventricular Remodeling

2003
Mineralocorticoid action and sodium-hydrogen exchange: studies in experimental cardiac fibrosis.
    Endocrinology, 2003, Volume: 144, Issue:9

    Topics: Animals; Anti-Arrhythmia Agents; Canrenoic Acid; Desoxycorticosterone; Fibrosis; Guanidines; Heart Diseases; Hydrogen; Male; Mineralocorticoid Receptor Antagonists; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Sodium; Sodium-Hydrogen Exchangers; Sulfones; Vasculitis

2003
Eplerenone, but not steroid withdrawal, reverses cardiac fibrosis in deoxycorticosterone/salt-treated rats.
    Endocrinology, 2004, Volume: 145, Issue:7

    Topics: Animals; Biomarkers; Coronary Vessels; Desoxycorticosterone; Eplerenone; Fibrosis; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Sodium Chloride, Dietary; Spironolactone; Vasculitis

2004
Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with
    Journal of the American College of Cardiology, 2004, Apr-21, Volume: 43, Issue:8

    Topics: Animals; Blotting, Western; Cardiac Output, Low; Desoxycorticosterone; Diastole; Fenofibrate; Fibrosis; Gene Expression; Hemodynamics; Hypertension; Hypolipidemic Agents; I-kappa B Proteins; Male; Myocardium; NF-kappa B; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; Sodium Chloride; Transcription Factors

2004
Tranilast attenuates myocardial fibrosis in association with suppression of monocyte/macrophage infiltration in DOCA/salt hypertensive rats.
    Journal of hypertension, 2004, Volume: 22, Issue:5

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Body Weight; Cardiomegaly; Chemokine CCL2; Collagen Type I; Collagen Type III; Desoxycorticosterone; Fibrosis; Hypertension; Interleukin-6; Macrophages; Male; Monocytes; Myocardium; Nephrectomy; Organ Size; ortho-Aminobenzoates; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sodium Chloride, Dietary; Transforming Growth Factor beta; Transforming Growth Factor beta1

2004
The potential advantage of omapatrilat: dual anti-fibrotic and anti-inflammatory effects in one single molecule.
    Journal of hypertension, 2005, Volume: 23, Issue:2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Cell Adhesion Molecules; Desoxycorticosterone; Drug Therapy, Combination; Fibrosis; Heart Diseases; Hypertension; Inflammation; Kidney Diseases; Metalloendopeptidases; Neprilysin; Organophosphonates; Pyridines; Rats; Thiazepines

2005
Dual angiotensin-converting enzyme/neutral endopeptidase inhibition on cardiac and renal fibrosis and inflammation in DOCA-salt hypertensive rats.
    Journal of hypertension, 2005, Volume: 23, Issue:2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Cell Adhesion Molecules; Collagen; Desoxycorticosterone; Drug Therapy, Combination; Enalapril; Fibrosis; Heart Diseases; Hypertension; Inflammation; Kidney Diseases; Metalloendopeptidases; Neprilysin; NF-kappa B; Organophosphonates; Pyridines; Rats; Rats, Sprague-Dawley; Thiazepines

2005
Kallikrein gene transfer reduces renal fibrosis, hypertrophy, and proliferation in DOCA-salt hypertensive rats.
    American journal of physiology. Renal physiology, 2005, Volume: 289, Issue:3

    Topics: Animals; Cell Cycle Proteins; Cell Division; Cyclic GMP; Cyclin-Dependent Kinase Inhibitor p27; Desoxycorticosterone; Disease Models, Animal; Extracellular Matrix; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Gene Transfer Techniques; Genetic Therapy; Hypertension, Renal; Hypertrophy; JNK Mitogen-Activated Protein Kinases; Kallikreins; Male; Nitrates; Oxidative Stress; Proteinuria; Rats; Rats, Sprague-Dawley; Sodium Chloride, Dietary; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Suppressor Proteins

2005
Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension.
    American journal of physiology. Heart and circulatory physiology, 2006, Volume: 290, Issue:6

    Topics: Angiotensin I; Animals; Blood Pressure; Cardiomegaly; Collagen; Coronary Vessels; Desoxycorticosterone; Dose-Response Relationship, Drug; Fibrosis; Heart Diseases; Hypertension; Male; Peptide Fragments; Rats; Rats, Sprague-Dawley; Ventricular Remodeling

2006
SGK1-dependent cardiac CTGF formation and fibrosis following DOCA treatment.
    Journal of molecular medicine (Berlin, Germany), 2006, Volume: 84, Issue:5

    Topics: Angiotensins; Animals; Blood Pressure; Connective Tissue Growth Factor; Desoxycorticosterone; Fibrosis; Heart; Heart Diseases; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Male; Mice; Mice, Mutant Strains; Mineralocorticoid Receptor Antagonists; Myocardium; NF-kappa B; Protein Serine-Threonine Kinases; Receptors, Mineralocorticoid; Salts; Spironolactone

2006
Mineralocorticoid receptor blockade but not steroid withdrawal reverses renal fibrosis in deoxycorticosterone/salt rats.
    Endocrinology, 2006, Volume: 147, Issue:7

    Topics: Animals; Collagen; Cyclooxygenase 2; Desoxycorticosterone; Fibrosis; Heme Oxygenase-1; Inflammation; Kidney; Male; Osteopontin; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; Sialoglycoproteins; Steroids

2006
Rosuvastatin attenuates hypertension-induced cardiovascular remodeling without affecting blood pressure in DOCA-salt hypertensive rats.
    Journal of cardiovascular pharmacology, 2006, Volume: 47, Issue:3

    Topics: Animals; Aorta; Blood Pressure; Desoxycorticosterone; Fibrosis; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypertrophy; Male; Myocardium; Pyrimidines; Rats; Rats, Wistar; Rosuvastatin Calcium; Sodium Chloride, Dietary; Sulfonamides; Ventricular Remodeling

2006
Attenuation of cardiovascular remodeling in DOCA-salt rats by the vasopeptidase inhibitor, omapatrilat.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2006, Volume: 28, Issue:5

    Topics: Action Potentials; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta, Thoracic; Blood Pressure; Desoxycorticosterone; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Fibrosis; Heart Ventricles; Hypertension; Hypertrophy; Inflammation; Male; Membrane Potentials; Metalloendopeptidases; Myocardial Contraction; Papillary Muscles; Pyridines; Rats; Rats, Wistar; Sodium Chloride, Dietary; Thiazepines; Ventricular Remodeling

2006
The role of the glucocorticoid receptor in mineralocorticoid/salt-mediated cardiac fibrosis.
    Endocrinology, 2006, Volume: 147, Issue:12

    Topics: Animals; Blood Pressure; Desoxycorticosterone; Dose-Response Relationship, Drug; Fibrosis; Inflammation Mediators; Male; Mifepristone; Mineralocorticoids; Myocardium; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Sodium Chloride, Dietary

2006
Does glucocorticoid receptor blockade exacerbate tissue damage after mineralocorticoid/salt administration?
    Endocrinology, 2007, Volume: 148, Issue:10

    Topics: Animals; Biomarkers; Blood Pressure; Cardiomegaly; Cardiomyopathies; Coronary Vessels; Desoxycorticosterone; Drug Administration Schedule; Eplerenone; Fibrosis; Hormone Antagonists; Male; Mifepristone; Myocardium; Organ Size; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Signal Transduction; Sodium Chloride; Spironolactone; Vasculitis

2007
Spironolactone suppresses peritubular capillary loss and prevents deoxycorticosterone acetate/salt-induced tubulointerstitial fibrosis.
    Hypertension (Dallas, Tex. : 1979), 2008, Volume: 51, Issue:3

    Topics: Animals; Apoptosis; Capillaries; Connective Tissue Growth Factor; Desoxycorticosterone; Endothelium, Vascular; Fibrosis; Hypoxia-Inducible Factor 1, alpha Subunit; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Kidney Tubules; Male; Mineralocorticoid Receptor Antagonists; Nephritis, Interstitial; Rats; Rats, Sprague-Dawley; Sodium Chloride; Spironolactone; Thrombospondin 1; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A

2008
Aldosterone: from biosynthesis to non-genomic action onto the proteome.
    Steroids, 2008, Volume: 73, Issue:9-10

    Topics: Adrenal Glands; Aldosterone; Animals; Calcium; Corticosterone; Cytochrome P-450 CYP11B2; Desoxycorticosterone; Fibrosis; Genome; Hormones; Humans; Models, Biological; Proteome; Proteomics; Steroids

2008
Determinants of cardiac fibrosis in experimental hypermineralocorticoid states.
    The American journal of physiology, 1995, Volume: 269, Issue:4 Pt 1

    Topics: Adrenalectomy; Aldosterone; Animals; Desoxycorticosterone; Drug Combinations; Fibrosis; Fludrocortisone; Heart; Hormone Antagonists; Male; Mifepristone; Mineralocorticoid Receptor Antagonists; Myocardium; Nephrectomy; Potassium; Rats; Rats, Sprague-Dawley; Spironolactone

1995
Respective role of humoral factors and blood pressure in cardiac remodeling of DOCA hypertensive rats.
    Cardiovascular research, 1996, Volume: 31, Issue:2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Bosentan; Calcium Channel Blockers; Cardiomegaly; Collagen; Coronary Circulation; Desoxycorticosterone; Enalapril; Endothelin Receptor Antagonists; Fibrosis; Hypertension; Male; Mibefradil; Myocardium; Perfusion; Rats; Rats, Wistar; Sulfonamides; Tetrahydronaphthalenes

1996
Adrenomedullin gene delivery attenuates hypertension, cardiac remodeling, and renal injury in deoxycorticosterone acetate-salt hypertensive rats.
    Hypertension (Dallas, Tex. : 1979), 2000, Volume: 36, Issue:6

    Topics: Adenoviridae; Adrenomedullin; Animals; Cardiomegaly; Cyclic AMP; Cyclic GMP; Desoxycorticosterone; Disease Models, Animal; Fibrosis; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Humans; Hypertension; Kidney Diseases; Male; Peptides; Rats; Rats, Sprague-Dawley; Systole

2000
Myocardial fibrosis in DOCA-salt hypertensive rats: effect of endothelin ET(A) receptor antagonism.
    Circulation, 2001, Jan-16, Volume: 103, Issue:2

    Topics: Animals; Atrasentan; Blood Pressure; Collagen; Collagen Type I; Desoxycorticosterone; Endothelin A Receptor Antagonists; Fibrosis; Hypertension; Male; Myocardium; Organ Size; Pyrrolidines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sodium Chloride; Transforming Growth Factor beta; Transforming Growth Factor beta1

2001
Experimental cardiac fibrosis: differential time course of responses to mineralocorticoid-salt administration.
    Endocrinology, 2001, Volume: 142, Issue:8

    Topics: Animals; Blood Pressure; Cardiomyopathies; Collagen; Desoxycorticosterone; Fibrosis; Heart; Male; Myocardium; Rats; Rats, Sprague-Dawley; Sodium Chloride; Time Factors

2001
Attenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA-salt hypertensive rats.
    British journal of pharmacology, 2002, Volume: 135, Issue:4

    Topics: Amiloride; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aorta, Thoracic; Biological Availability; Collagen; Desoxycorticosterone; Fibrosis; Hypertension; Hypertrophy, Left Ventricular; Muscle Contraction; Muscle, Smooth, Vascular; Myocardial Contraction; Myocardium; Norepinephrine; Pyridones; Rats; Rats, Wistar; Sodium Chloride, Dietary; Vasoconstrictor Agents

2002
Fibrosis, matrix metalloproteinases, and inflammation in the heart of DOCA-salt hypertensive rats: role of ET(A) receptors.
    Hypertension (Dallas, Tex. : 1979), 2002, Volume: 39, Issue:2 Pt 2

    Topics: Animals; Desoxycorticosterone; Fibrosis; Heart Diseases; Hypertension; Male; Matrix Metalloproteinases; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptors, Endothelin; Ventricular Remodeling

2002
The alpha8 integrin chain affords mechanical stability to the glomerular capillary tuft in hypertensive glomerular disease.
    The American journal of pathology, 2002, Volume: 160, Issue:3

    Topics: Animals; Capillaries; Desoxycorticosterone; Fibrosis; Hypertension, Renal; Integrin alpha Chains; Integrins; Kidney Glomerulus; Mice

2002